In addition, among the cohort of our study participants, individuals of higher age had lower GSH concentrations in the overall and parietal regions at baseline
Semaglutide Dosing# FDA-approved dosing with established protocols: Ozempic (T2D) : Start 0.25 mg weekly, escalate to 0.5-2 mg over 8-16 weeks Wegovy (obesity) : Start 0.25 mg weekly, escalate through 0.5, 1.0, 1.7, to 2.4 mg maintenance over 16 weeks Rybelsus (oral T2D) : Start 3 mg daily, escalate to 7-14 mg daily over 30-60 days Semaglutide benefits from established guidelines for missed doses, switching between formulations, special populations (renal/hepatic impairment, elderly), and drug interactions
June 26, 2024
Specifically, we do not know what component of GLP-1 effects is attributable not to risk factor modulation, but rather to processes acting directly on the heart
Lydia Alexander, past president of the Obesity Medicine Association